Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.

The Wall Street Journal

Dave Ricks is pushing his scientists to find an even more potent anti-obesity treatment. “Lilly’s got a lead, and we plan to exploit that lead.”